Fetuin-A characteristics during and after pregnancy: Result from a case control pilot study

International Journal of Endocrinology

Volumn 2012, Issue , 2012, Pages

  Farhan, Serdar ^a   Handisurya, Ammon ^b   Todoric, Jelena ^b   Tura, Andrea ^c   Pacini, Giovanni ^c   Wagner, Oswald ^d   Klein, Katharina ^e   Jarai, Rudolf ^a   Huber, Kurt ^a   Kautzky Willer, Alexandra ^b  

^a WILHELMINEN HOSPITAL   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c CNR   (Italy)

^d UNIVERSITY OF VIENNA   (Austria)

^e UNIV KLIN FÜR FRAUENHEILKUNDE   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; C PEPTIDE; CHOLESTEROL; CHOLINESTERASE; FETUIN A; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BODY MASS; CASE CONTROL STUDY; CHOLESTEROL BLOOD LEVEL; CHOLINESTERASE BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GESTATIONAL AGE; GLUCOSE BLOOD LEVEL; GLUCOSE INTAKE; GLUCOSE TOLERANCE; HUMAN; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; ORAL GLUCOSE TOLERANCE TEST; PILOT STUDY; POSTPRANDIAL STATE; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PUERPERIUM; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 84859762014     PISSN: 16878337     EISSN: 16878345     Source Type: Journal    
DOI: 10.1155/2012/896736     Document Type: Article

References (14)

1. Schfer C., Heiss A., Schwarz A., Westenfeld R., Ketteler M., Floege J., Mller-Esterl W., Schinke T., Jahnen-Dechent W., The serum protein 2 -Heremans-Schmid glycoprotein/ fetuin-A is a systemically acting inhibitor of ectopic calcification Journal of Clinical Investigation 2003 112 3 357 366 (Pubitemid 38063764)
2. Auberger P., Falquerho L., Contreres J. O., Pages G., Le Cam G., Rossi B., Le Cam A., Characterization of a natural inhibitor of the insulin receptor tyrosine kinase: cDNA cloning, purification, and anti-mitogenic activity Cell 1989 58 4 631 640 (Pubitemid 19210957)
3. Mathews S. T., Chellam N., Srinivas P. R., Cintron V. J., Leon M. A., Goustin A. S., Grunberger G., 2 -HSG, a specific inhibitor of insulin receptor autophosphorylation, interacts with the insulin receptor Molecular and Cellular Endocrinology 2000 164 1-2 87 98 (Pubitemid 30665503)
4. Ix J. H., Shlipak M. G., Brandenburg V. M., Ali S., Ketteler M., Whooley M. A., Association between human fetuin-A and the metabolic syndrome: data from the heart and soul study Circulation 2006 113 14 1760 1767 (Pubitemid 43958469)
5. Ix J. H., Wassel C. L., Kanaya A. M., Vittinghoff E., Johnson K. C., Koster A., Cauley J. A., Harris T. B., Cummings S. R., Shlipak M. G., Fetuin-A and incident diabetes mellitus in older persons JAMAJournal of the American Medical Association 2008 300 2 182 188 (Pubitemid 351969302)
6. Stefan N., Hennige A. M., Staiger H., Machann J., Schick F., Krber S. M., Machicao F., Fritsche A., Hring H. U., 2 -Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans Diabetes Care 2006 29 4 853 857 (Pubitemid 44115306)
7. Kalabay L., Cseh K., Pajor A., Baranyi., Cskny G. M., Melczer Z., Speer G., Kovcs M., Siller G., Kardi I., Winkler G., Correlation of maternal serum fetuin/ 2 -HS-glycoprotein concentration with maternal insulin resistance and anthropometric parameters of neonates in normal pregnancy and gestational diabetes European Journal of Endocrinology 2002 147 2 243 248
8. American Diabetes Association, Clinical practice recommendations Diabetes Care 2002 25 supplement 1 S1 S14
9. Mari A., Pacini G., Murphy E., Ludvik B., Nolan J. J., A model-based method for assessing insulin sensitivity from the oral glucose tolerance test Diabetes Care 2001 24 3 539 548 (Pubitemid 32198427)
10. Kautzky-Willer A., Tura A., Winzer C., Wagner O. F., Ludvik B., Hanusch-Enserer U., Prager R., Pacini G., Insulin sensitivity during oral glucose tolerance test and its relations to parameters of glucose metabolism and endothelial function in type 2 diabetic subjects under metformin and thiazolidinedione Diabetes, Obesity and Metabolism 2006 8 5 561 567 (Pubitemid 44184250)
11. Tura A., Ludvik B., Nolan J. J., Pacini G., Thomaseth K., Insulin and C-peptide secretion and kinetics in humans: direct and model-based measurements during OGTT American Journal of Physiology 2001 281 5 E966 E974
12. Takata H., Ikeda Y., Suehiro T., Ishibashi A., Inoue M., Kumon Y., Terada Y., High glucose induces transactivation of the 2 -HS glycoprotein gene through the ERK1/2 signaling pathway Journal of Atherosclerosis and Thrombosis 2009 16 4 448 456
13. Brix J. M., Stingl H., Hllerl F., Schernthaner G. H., Kopp H. P., Schernthaner G., Elevated fetuin-A concentrations in morbid obesity decrease after dramatic weight loss Journal of Clinical Endocrinology and Metabolism 2010 95 11 4877 4881
14. Reinehr T., Roth C. L., Fetuin-A and its relation to metabolic syndrome and fatty liver disease in obese children before and after weight loss Journal of Clinical Endocrinology and Metabolism 2008 93 11 4479 4485 (Pubitemid 352789550)